Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma.

Wang W, Jiang H, Zhu H, Zhang H, Gong J, Zhang L, Ding Q.

Oncol Lett. 2013 Mar;5(3):884-888. Epub 2012 Dec 27.


The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.

Takeda T, Izumi H, Kitada S, Uramoto H, Tasaki T, Zhi L, Guo X, Kawatsu Y, Kimura T, Horie S, Nabeshima A, Noguchi H, Wang KY, Sasaguri Y, Kohno K, Yamada S.

Tumour Biol. 2014 Oct;35(10):10555-69. doi: 10.1007/s13277-014-2328-8. Epub 2014 Jul 26.


High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.

Liu F, Zhang Y, Peng Z, Gao H, Xu L, Chen M.

J Transl Med. 2012 Jul 2;10:135. doi: 10.1186/1479-5876-10-135.


Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.

Takaishi H, Kanai T, Nakazawa A, Sugata F, Nikai A, Yoshizawa S, Hamamoto Y, Funakoshi S, Yajima T, Iwao Y, Takemura M, Ozaki S, Hibi T.

J Gastroenterol. 2012 Sep;47(9):969-77. doi: 10.1007/s00535-012-0566-3. Epub 2012 May 30.


Overexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma.

Kwon JH, Kim J, Park JY, Hong SM, Park CW, Hong SJ, Park SY, Choi YJ, Do IG, Joh JW, Kim DS, Choi KY.

Clin Cancer Res. 2010 Nov 15;16(22):5511-21. doi: 10.1158/1078-0432.CCR-10-0825. Epub 2010 Sep 17.


Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.

Li T, Gui Y, Yuan T, Liao G, Bian C, Jiang Q, Huang S, Liu B, Wu D.

BJU Int. 2012 Dec;110(11 Pt C):E1125-30. doi: 10.1111/j.1464-410X.2012.11277.x. Epub 2012 Jun 6.


High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progression.

Chung HW, Lim JB.

Cancer Sci. 2017 Jun 2. doi: 10.1111/cas.13288. [Epub ahead of print]


Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.

He W, Tang B, Yang D, Li Y, Song W, Cheang T, Chen X, Li Y, Chen L, Zhan W, Li W, He Y.

World J Surg Oncol. 2013 Jul 18;11:161. doi: 10.1186/1477-7819-11-161.


High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.

Jiang W, Wang Z, Li X, Fan X, Duan Y.

Pathol Oncol Res. 2012 Apr;18(2):293-8. doi: 10.1007/s12253-011-9442-3. Epub 2011 Sep 7.


Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.

Miyake M, Fujimoto K, Anai S, Ohnishi S, Kuwada M, Nakai Y, Inoue T, Matsumura Y, Tomioka A, Ikeda T, Tanaka N, Hirao Y.

Oncol Rep. 2011 Mar;25(3):653-60. doi: 10.3892/or.2010.1125. Epub 2010 Dec 27.


High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer.

Miyata Y, Watanabe S, Sagara Y, Mitsunari K, Matsuo T, Ohba K, Sakai H.

PLoS One. 2013;8(3):e59095. doi: 10.1371/journal.pone.0059095. Epub 2013 Mar 13.


[Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].

Zhang G, Zhao M, Xu M, Yang Y, Wang M, Yang C.

Zhonghua Jie He He Hu Xi Za Zhi. 2002 Feb;25(2):89-93. Chinese.


Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.

Strohmeyer D, Strauss F, Rössing C, Roberts C, Kaufmann O, Bartsch G, Effert P.

Anticancer Res. 2004 May-Jun;24(3a):1797-804.


Prognostic significance of angiogenesis in superficial bladder cancer.

Stavropoulos NE, Bouropoulos C, Ioachim IE, Michael M, Hastazeris K, Tsimaris I, Kalogeras D, Liamis Z, Stefanaki S, Agnantis NI.

Int Urol Nephrol. 2004;36(2):163-7.


The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.

Inoue K, Kamada M, Slaton JW, Fukata S, Yoshikawa C, Tamboli P, Dinney CP, Shuin T.

Clin Cancer Res. 2002 Jun;8(6):1863-70.


Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer.

Strohmeyer D, Rössing C, Bauerfeind A, Kaufmann O, Schlechte H, Bartsch G, Loening S.

Prostate. 2000 Nov 1;45(3):216-24.


Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1.

van Beijnum JR, Nowak-Sliwinska P, van den Boezem E, Hautvast P, Buurman WA, Griffioen AW.

Oncogene. 2013 Jan 17;32(3):363-74. doi: 10.1038/onc.2012.49. Epub 2012 Mar 5.


Supplemental Content

Support Center